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ABSTRACT
Objective: The aim was to develop a simple, rapid, less expensive, linear, precise, and accurate reverse phase high performance liquid chromatography 
method for determination of nifedipine in tablets.
Methods: The chromatographic analysis of nifedipine was performed using liquid chromatograph Agilent 1290 Infinity II LC System. Selected 
conditions were isocratic elution with binary mobile phase consisting of solution methanol and 0.1% trifluoroacetic acid (55:45). Detection was 
carried out using spectrophotometric detector at 265 nm. The method was validated as per ICH guidelines.
Results: The retention time for nifedipine by proposed high performance liquid chromatography (HPLC) method is observed as 3.5 minutes. The 
correlation coefficients are 1.0000. The developed chromatographic method was found to be accurate with recovery 99.2-99.8% and was found 
within the acceptance criteria (i.e. 98.0-102.0%) with acceptable % relative standard deviation of not more than 2% at each level. The assay results of 
nifedipine in tablets by developed method are highly reproducible, reliable and are in good agreement with the label claim of the medicines (average 
99.62 %).
Conclusion: Finally, it should be noted that a new simple, rapid, linear, precise, accurate HPLC method was developed and validated for the 
determination of nifedipine in medicines in accordance with the ICH guidelines. These results show the method are accurate, precise, sensitive, 
economic, and rugged. The proposed HPLC method is rapider (retention time is 3.5 minutes). This method can be useful for the routine analysis of 
nifedipine in pharmaceutical dosage form.
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INTRODUCTION
One of the important problems of modern pharmaceutical science is 
to replenish the range of new medicines and scientific justification 
of their application in clinical medicine. Increasing the number of 
antihypertensive medicines and different chemical substances and 
the need to identify them in present another active pharmaceutical 
ingredients are constantly put before standardization of medicines and 
pharmaceutical chemistry task of improving existing and developing 
new methods of analysis. In this regard, increasing the role of 
chromatographic methods, and especially - highly efficient options for 
liquid chromatography (HPLC). Nowadays spectroscopy with liquid and 
gas chromatography are the most common instrumental methods of 
analysis. Over the past decade developed spectrophotometric methods 
for determining amlodipine, nifedipine, verapamil, captopril, fosinopril, 
diltiazem in substance and dosage forms, and conducted validation and 
verification spectrophotometric techniques developed in compliance 
with pharmacopoeias. Along with the unexplored issue is the development 
of chromatographic methods for analysis of antihypertensive medicines 
in the standardization of this pharmacological group of medicines [1-6].
Nifedipine, dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-
dihydropyridine-3,5-dicarboxylate, is a potent dihydropyridine-type 
calcium channel blocker which is an antihypertensive medicine. 
The pharmacopoeial chromatographic conditions are column 
chromatographic categories L1 (with a fixed phase C18) size of 4.6 mm 
× 250 mm; mobile phase - acetonitrile:methanol:water (25:25:50); 
wavelength - 265 nm, flow rate - 1.0 ml/minutes [7]. Our goal was to 
improve HPLC methods of analysis of nifedipine in medicines [8,9].
The aim of work was the development of simple, expressive, accurate, 
and less expensive analytical methods for the determination of 
nifedipine in medicines by HPLC.
METHODS
Instrumental and analytical conditions
In developing this technique, column Ascentis C18 was used, which has 
several advantages from a number of columns L1 and provides high 
speed and high efficiency at a lower pressure system. This reduces the 
number of used mobile phase that according reduces the cost analysis.
Selected conditions were isocratic elution with binary mobile phase 
consisting of methanol and 0.1% trifluoroacetic acid solution in the 
ratio of 55:45 for optimum peak symmetry of the active ingredient. 
Besides reducing the analysis time are achieved by increasing the flow 
rate of 1.5 mL/minutes and column temperature increase to 35°C.
The chromatographic analysis of nifedipine performed on liquid 
chromatograph Agilent 1290 Infinity II LC System.
The brief scheme of the experiment:
•	 Column:	Ascentis	express	C18	column	size	4.6	mm	×	150	mm	with	
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Reagents and chemicals
Nifedipine was obtained as gift sample form company “Zdorovja” 
(Ukraine). Trade name of nifedipine is “Fenigidin Zdorovja.” Tablets 




Preparation of sample solution
To 200.0 mg powder pounded tablets, add 10 ml of methanol R, shake 
in ultrasonic bath for 10 minutes and add methanol R to the volume 
of 20.0 ml. Filter through a membrane filter with a pore size of 0.45 µ, 
discarding the first 5 ml of filtrate. 2.0 ml of the resulting filtrate 
adjusted to 20.0 ml of solvent.
Preparation of standard solution
20.0 mg of nifedipine SPhU dissolve in methanol R and dilute with 
the same solvent to 20.0 ml volume. 2.0 ml of the resulting solution 
adjusted to 20.0 ml of solvent.
RESULTS
For elaboration of the method the chromatograms of the standard 
solution of nifedipine (Fig. 1) and the sample solution of nifedipine 
(Fig. 2), as well as the dependence of the intensity peaks on the 
retention time were obtained and analyzed.
The chromatographic system is considered suitable if the following 
conditions are performed:
•	 The	effectiveness	of	the	chromatographic	column,	calculated	peak	
of nifedipine should be not <4000 theoretical plates;
•	 Relative	standard	deviation	(RSD)	calculated	peak	area	for	nifedipine	
should be not more than 1.0%;
•	 Symmetry	factor	calculated	on	the	peak	of	nifedipine	should	be	<1.5.
The content of nifedipine (X) in one tablet, in milligrams, was calculated 
by the formula. Calculation formula:
X S m b  S B
i o
o i
= ⋅ ⋅ ⋅⋅ ⋅100
Where,
Si - Average of the peak areas of nifedipine, calculated from the 
chromatograms of the sample solutions;




P - Content of the main substance in SPhU nifedipine as a percentage;
b - Average of weight tablets in milligrams.
Method validation
Validation of an analytical procedure involves analytical tasks are 
articulated clearly - for what purpose the analytical procedure is used. 
We	 have	 studied	 the	 following	 validation	 characteristics:	 Linearity,	
accuracy and precision, range of application [10-12].
The statistical quantities and validation parameters were shown in 
Tables 1 and 2, Figs. 3 and 4.
DISCUSSION
In the work, a solution containing a mixture of the placebo was 
prepared using the sample preparation procedure to evaluate possible 
interfering peaks. The investigated chromatograms did not show any 
other substances peaks, which prove the specificity of the developed 
method.
Evaluation of linearity was performed on the range of application of the 
method using standard method. The results obtained were statistically 
processed by the least squares method according to the requirements 
of the SPhU and ICH guidelines. Calculation of the linear relationship 
Y=mX+b was conducted by the least square method. The linearity plot 
of nifedipine is found linear and correlation coefficient 1.00000 for 
nifedipine. This performs that the method is linear in the specified 
range for the analysis of nifedipine in tablets.
The precision of an analytical procedure expresses the closeness of 
agreement between a series of measurement obtained from multiple 
sampling of the same sample under prescribed conditions. Accuracy 
and precision were studied by method “put-found” on standard 
solutions of nifedipine. The proposed chromatographic method was 
found to be accurate with recovery 99.2-99.8% and was found within 
the acceptance criteria (i.e., 98.0-102.0%) with acceptable % RSD 
of not more than 2% at each analyte level. Precision was calculated 
as repeatability and intraday and interday variation for nifedipine. 
The proposed method was found to be precise with coefficient of 
variance=0.5 for intraday and interday for nifedipine.
Fig. 1: High performance liquid chromatography chromatograms of the standard solution of nifedipine in the terms of the quantification 
of nifedipine in tablets
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Fig. 2: High performance liquid chromatography chromatogram of the sample solution of nifedipine in the terms of the quantification of 
nifedipine in tablets
Fig. 3: Resolution of nifedipine in different areas high performance liquid chromatography
Table 1: The results of HPLC determination of nifedipine







RS 1 0.1080 - -
RS 2 0.0995 - -
MS	70% 0.0700 0.0690 98.6
MS	100% 0.0995 0.0993 99.8
MS	130% 0.1305 0.1300 99.6
The average 99.3
The RSD, Sz% 0.4137
Relative	confidence	interval,	∆z% 0.99
The	critical	value	for	convergence	results	∆z%≤3.2 Conform
The criterion of statistical insignificance 
systematic error
 = − ≤ ∆½ ½%  100 / nzZ
≤0.33 Conform
Criterion practical insignificance 
systematic error
% .  1 AS= − ≤ ∆½ ½Z 00 0 32
≤2.048 Conform
General conclusion about procedure Conform
HPLC: High performance liquid chromatography
152
Asian J Pharm Clin Res, Vol 10, Issue 3, 2017, 149-152
 Logoyda et al. 
Our study describes new HPLC method using simple chromatographic 
conditions for the determination of nifedipine in tablets. Under this 
conditions, the peak of nifedipine elution is about 3.5 minutes.
The assay results of the tablets “Fenigidin Zdorovja” by developed 
chromatographic method are highly reproducible, reliable and 
are in good agreement with the label claim of the medicines 
(average 99.62 %) (Table 3). This demonstrated excellent result.
CONCLUSION
Finally, it should be noted that a new simple, rapid, linear, precise, 
accurate HPLC method was developed and validated for the 
determination of nifedipine in medicines in accordance with the 
ICH guidelines. These results show the method is accurate, precise, 
sensitive, economic, and rugged. The proposed HPLC method is rapider 
(retention time is 3.5 minutes). This method can be useful for the 




to complete this research work.
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Table 2: Summary of validation parameters of nifedipine by 
proposed HPLC method
The slope of the linear relationship b 1.88499e-2
The constant term of the linear 
dependence m
9957.69116
The residual standard deviation Sr 0.32620
The correlation coefficient method r 1.00000
Accuracy, % 99.2-99.8






RSD: Relative standard deviation, HPLC: High performance liquid 
chromatography
Fig. 4: The linear relationship of the area on nifedipine concentration
Table 3: Assay results
Sample no Label claim (mg) % Amount found Average
1 10 99.8 99.62
2 10 99.6
3 10 99.6
4 10 99.7
5 10 99.4
6 10 99.6
